Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple pink liquid soothe your Baby's diaper rash?

NCT ID NCT05599763

Symptom relief Sponsor: Cooperation Pharmaceutique Francaise Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how well a 2% eosin solution (a pink liquid) works for diaper rash in babies under 2 years old. 67 children used the solution for 7 days. Researchers measured rash improvement using a scoring system. The goal was to see if the rash got better or cleared up completely.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
2% aqueous eosin solution
What this could lead to
If it works, this could confirm that 2% eosin is a safe and effective option for treating diaper rash in babies.
What could go wrong
This is a small, observational study with no comparison group, so results may not be definitive. The product is already on the market, so no major breakthrough is expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

67 people

The number who actually took part.

Started

Nov 2022

Finished

Apr 2023

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients seen in consultation by French general practitioners and pediatricians

Ages

Up to 24 months

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children under 24 months * With diaper rash for which a prescription for 2% aqueous eosin in a 50 ml vial is made * SSDDS score \>= 3/6 * Not requiring hospitalization * Written consent of one of the parents * Affiliated with social security * Acceptance of one of the parents to participate in a visit on day 7 in the office or, in case of impossibility, with video/internet consultation or with consultation by phone and sending a photo in this case by the parent(s). Exclusion Criteria: * Antibiotic therapy in progress or prescribed on day 0, or other local therapeutic topicals prescribed on day 0 * Children with wounds or likely to be allergic to 2% aqueous eosin or to one of the components of 2% aqueous eosin. * Ongoing diarrhoea (change in the consistency of stools (loose or watery) and / or an increase in the number (≥ 3 stools / day).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diaper rash are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Diaper Rash

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diaper rash

Contacts and locations

Locations

  • Multiple locations

    Multiple Locations, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.